Hyperdopaminergic states: a continuum.
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000209:etiology; D010830:Physostigmine / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use
D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D010830:Physostigmine; D006220:Haloperidol